8-K: Kenvue Shareholders Overwhelmingly Approve K-C Merger

Kenvue Inc. stockholders overwhelmingly approved the merger agreement with Kimberly-Clark Corporation, moving closer to forming a global health and wellness leader.

Summary

• Kenvue Inc. stockholders approved the Agreement and Plan of Merger with Kimberly-Clark Corporation at a virtual special meeting held on January 29, 2026.
• The Merger Proposal received 1,489,923,158 votes for, 7,467,731 votes against, and 3,274,116 abstentions, representing approximately 99% of shares voted and 77% of all outstanding shares.
• Stockholders also approved, on a non-binding advisory basis, the compensation for named executive officers related to the merger, with 1,465,779,826 votes for.
• The Adjournment Proposal was not submitted as sufficient votes were cast for the Merger Proposal.
• Kimberly-Clark shareholders also overwhelmingly approved the issuance of shares in connection with the transaction, with approximately 96% of shares present voting in favor.
• The transaction is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive development, as the overwhelming shareholder approval significantly de-risks the merger's completion and signals strong investor confidence in the strategic combination.

Positives

• Overwhelming shareholder approval from both Kenvue (approximately 99% of votes cast) and Kimberly-Clark (approximately 96% of shares present) for the merger.
• The merger is expected to create a preeminent global health and wellness leader with a combined portfolio of iconic, science-backed brands.
• Management anticipates the combination will accelerate innovation, expand access to trusted brands, deliver increased benefits to customers and consumers, and generate significant value for shareholders.

Risks

• The occurrence of any event, change, or circumstance that could lead to the termination of the merger agreement, potentially requiring a party to pay a termination fee.
• Conditions to the completion of the proposed transaction, including regulatory approvals, may not be satisfied in a timely manner or at all.
• The possibility that competing offers or transaction proposals may be made.
• Risks arising from the integration of the K-C and Kenvue businesses.
• Uncertainty of rating agency actions following the transaction.
• The anticipated benefits and synergies of the proposed transaction may not be realized when expected or at all.
• The proposed transaction may not be completed in a timely manner or at all.
• Risk of unexpected costs or expenses resulting from the proposed transaction.
• Risk of litigation related to the proposed transaction, including resulting expense or delay.
• Risks related to disruption to ongoing business operations and diversion of management's time due to the proposed transaction.
• The proposed transaction may have an adverse effect on the ability of K-C and Kenvue to retain key personnel, customers, and suppliers.
• The credit ratings of the combined company could decline following the proposed transaction.
• The announcement or consummation of the proposed transaction may have a negative effect on the market price of the capital stock of K-C and Kenvue or on their operating results.
• General economic and political conditions globally, including inflation, interest rate and currency exchange rate fluctuations, government trade actions, natural disasters, acts of war, terrorism, pandemics, and supply chain disruptions.
• Product liability litigation or government/regulatory action, including product recalls or safety concerns.
• Challenges inherent in new product research and development, and uncertainty of commercial success for new and existing products.
• Challenges to intellectual property protections, including counterfeiting.

Future Outlook

The transaction is expected to close in the second half of 2026, contingent upon the receipt of necessary regulatory approvals and the satisfaction of other customary closing conditions. Management anticipates the combined entity will become a preeminent global health and wellness leader, driving innovation and expanding market reach.

Management Comments

• "We are grateful to Kimberly-Clark shareholders who voted resoundingly in support of our combination with Kenvue. This is an exciting milestone and advances our efforts to create a preeminent global health and wellness leader that will raise the standard of care for billions of people around the world and generate significant value for shareholders." Mike Hsu, Kimberly-Clark Chairman and Chief Executive Officer.
• "We thank Kenvue shareholders for their strong support in approving our transaction with Kimberly-Clark. As we continue to progress toward completing the transaction later this year, we remain confident in the growth opportunities ahead for the combined company as a global health and wellness leader." Kirk Perry, Chief Executive Officer of Kenvue.
• "By bringing together our portfolios and teams, we can accelerate innovation, expand access to our trusted brands and deliver increased benefits to our customers and consumers worldwide." Kirk Perry, Chief Executive Officer of Kenvue.

Industry Context

StockSavvy.ai notes that this merger represents a significant consolidation in the consumer health and personal care sector, creating a formidable competitor with an expanded portfolio of household brands. The combination of Kenvue's pharmaceutical-adjacent consumer health products (e.g., Tylenol, Listerine) with Kimberly-Clark's personal care and hygiene staples (e.g., Huggies, Kleenex) aims to leverage cross-category synergies and market reach, positioning the new entity to compete more effectively against diversified giants like Procter & Gamble and Unilever, as well as other pure-play consumer health companies.

Stakeholder Impact

• Shareholders: Expected to benefit from the creation of a global health and wellness leader and significant value generation.
• Customers/Consumers: Anticipated to receive increased benefits through accelerated innovation and expanded access to trusted brands.
• Employees: Potential for disruption to ongoing business operations and challenges in retaining key personnel due to integration risks.
• Suppliers: Potential for disruption to relationships and changes in supply chain dynamics.

Next Steps

• Obtain necessary regulatory approvals.
• Satisfy other customary closing conditions.
• Complete the transaction, expected in the second half of 2026.
• File final vote results with the U.S. Securities and Exchange Commission in separate Current Reports on Form 8-K.

Key Dates

Recommendation

The overwhelming shareholder approval for the merger significantly reduces execution risk for this strategic transaction. The combined entity of Kenvue and Kimberly-Clark is poised to become a dominant force in consumer health and wellness, offering substantial long-term growth potential through expanded market reach, accelerated innovation, and synergistic benefits. This development provides a clear path forward for value creation, making the combined entity a compelling investment opportunity for long-term investors.

Keywords

Kenvue, Kimberly-Clark, Merger, Acquisition, Shareholder Vote, Consumer Health, Health and Wellness, SEC Filing, 8-K, Corporate Governance, KVUE, KMB